Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Survey of Neurologist's Current Practices in Evaluation of Multiple Sclerosis to Identify Domains for a New Clinician-Reported Measure.
Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS): Canadian contribution to the international validation project.
Longitudinal Relationships between Caloric Expenditure and Gray Matter in the Cardiovascular Health Study.
Albumin and multiple sclerosis.
Reliability and validity of the function in sitting test in nonambulatory individuals with multiple sclerosis.
Homeostasis of Microglia in the Adult Brain: Review of Novel Microglia Depletion Systems.
CNS myelin structural modification induced in vitro by phospholipases A2.
[Neuroprotective effect screening and the mechanism of 10 kinds of coumarin derivatives].
Consensus Management of Gastrointestinal Events Associated with Delayed-Release Dimethyl Fumarate: A Delphi Study.
Regulator of G-protein Signaling (RGS)1 and RGS10 Proteins as Potential Drug Targets for Neuroinflammatory and Neurodegenerative Diseases.
How Fatigue Influences Exercise Participation in Men With Multiple Sclerosis.
Clinical and demographical characteristics of primary progressive multiple sclerosis in Isfahan, Iran.
Therapy Adherence In Patients With Multiple Sclerosis Using An Electronic Multidose Auto-Injection Device.
Novel p75 neurotrophin receptor ligand stabilizes neuronal calcium, preserves mitochondrial movement and protects against HIV associated neuropathogenesis.
Neurodegeneration in multiple sclerosis is a process separate from inflammation: No.
Patterns Of Use Of Tests To Monitor Disease Activity Among Patients Currently Treated For Relapsing Remitting Multiple Sclerosis (Rrms) In Europe.
The Rao's Brief Repeatable Battery version B: normative values with age, education and gender corrections in an Italian population.
Neurosarcoidosis: Clinical Features, Diagnosis, and Management.
A significant decrease in diagnosis of primary progressive multiple sclerosis: A cohort study.
Anti-annexin antibodies, cholesterol levels and disability in multiple sclerosis.
Regulation of oligodendrocyte precursor maintenance by chondroitin sulphate glycosaminoglycans.
[Symptoms and neurological findings in patients with multiple sclerosis].
Increased interleukin-6 correlates with myelin oligodendrocyte glycoprotein antibodies in pediatric monophasic demyelinating diseases and multiple sclerosis.
[Molecular genetic characteristics of the virus isolated from patients with human acute encephalomyelitis and multiple sclerosis].
Clinical associations between gout and multiple sclerosis, Parkinson's disease and motor neuron disease: record-linkage studies.
Pages
« first
‹ previous
…
713
714
715
716
717
718
719
720
721
…
next ›
last »